The 10 highest-selling drugs in the U.S. last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted almost $58 billion in sales, Axios’ Bob Herman reports. The big picture: The U.S. drug pricing system is filled with confusing numbers, and many entities profit off the flow of drugs,

Read more on Axios